Resibufogenin
Cat. No.：YN482563
CAS No. ：465-39-4
| 产品名称: | Resibufogenin |
| CAS No.: | 465-39-4 |
| Chemical Name: | (3β,5β,15β)-14,15-epoxy-3-hydroxy-bufa-20,22-dienolide |
| Synonyms: | 酯蟾毒配基; Bufogenin; Recibufogenin |
| 分子量: | 384.51 |
| 分子式: | C₂₄H₃₂O₄ |
| SMILES: | C[C@]([C@@H](C(C=C1)=COC1=O)C2)(CC[C@@]3([H])[C@@]4([H])CC[C@@]5([H])[C@@]3(CC[C@H](O)C5)C)[C@@]64[C@@H]2O6 |
| 存储: | Please store the product under the recommended conditions in theCertificate of Analysis. |
| 运输: | Room temperature in continental US; may vary elsewhere. |
| 产品描述: | 酯蟾毒配基 (Resibufogenin) 是华蟾素的一种成分，具有抑制氧化应激及肿瘤再生的功能。 |
| IC50和靶点: | |
| In Vitro: | |
| In Vivo: | |
| Clinical Trial: | |
| Solvent & Solubility: |
Pamnani, M.B., Chen, S., Bryant, H.J., et al.Effects of three sodium-potassium adenosine triphosphatase inhibitorsHypertension18(3),316-324(1991)
Iwatsuki, K., Yusa, T., Kataoka, Y., et al.Experimental and clinical studies of resibufogeninTohoku J. Exp. Med.86(2),93-101(1965)
Puschett, J.B., Agunanne, E., and Uddin, M.N.Marinobufagenin, resibufogenin and preeclampsiaBiochim. Biophys. Acta1802(12),1246-1253(2010)
Ichikawa, M., Sowa, Y., Iizumi, Y., et al.Resibufogenin induces G1-phase arrest through the proteasomal degradation of cyclin D1 in human malignant tumor cellsPLoS One10(6),(2015)
